A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson's disease
[article]
2018
bioRxiv
pre-print
Reduced levels of dopamine in Parkinson's disease (PD) contribute to changes in learning, resulting from the loss of midbrain dopamine neurons that transmit a teaching signal to the striatum. Dopamine medication used by PD patients has previously been linked to either behavioral changes during learning itself or adjustments in approach and avoidance behavior after learning. To date, however, very little is known about the specific relationship between dopaminergic medication-driven differences
doi:10.1101/445528
fatcat:p2i4yasknverboimmcv5qvmrje